Histaminergic systems and sleep. Studies in man with H1 and H2 antagonists.

作者: A.N. Nicholson , Peta A. Pascoe , Barbara M. Stone

DOI: 10.1016/0028-3908(85)90081-4

关键词: WakefulnessHistaminergicMepyramineEndocrinologyPharmacologyRapid eye movement sleepTriprolidineSlow-wave sleepPsychologyInternal medicineMequitazineBrompheniramine

摘要: Abstract Effects of H1 (mepyramine, mequitazine, triprolidine and brompheniramine) H2 (cimetidine ranitidine) antagonists on sleep were studied in healthy man. There no effects mepyramine (50 100mg), the only effect mequitazine (5 10mg) was a reduction number awakenings. Triprolidine (10 20 mg) brompheniramine (4 8mg) did not alter wakefulness during or total time, but rapid eye movement reduced. ranitidine (150 300 mg), slow wave increased by cimetidine (200 400 mg). It is tentatively suggested that histaminergic system concerned with mechanisms which favour vigilance wakeful state, balance between activity sleep. some antihistamines are believed to be due their monoaminergic rather than activity.

参考文章(28)
G. E. P. Box, D. R. Cox, An Analysis of Transformations Journal of the Royal Statistical Society: Series B (Methodological). ,vol. 26, pp. 211- 243 ,(1964) , 10.1111/J.2517-6161.1964.TB00553.X
Francis John Anscombe, Examination of Residuals Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, Volume 1: Contributions to the Theory of Statistics. pp. 1- 36 ,(1961)
M J Hughes, I A Coret, EFFECTS OF TRICYCLIC COMPOUNDS ON THE HISTAMINE RESPONSE OF ISOLATED ATRIA Journal of Pharmacology and Experimental Therapeutics. ,vol. 191, pp. 252- 261 ,(1974)
A. N. Nicholson, B. M. Stone, The H2-antagonists, cimetidine and ranitidine: studies on performance. European Journal of Clinical Pharmacology. ,vol. 26, pp. 579- 582 ,(1984) , 10.1007/BF00543488
Takehiko Watanabe, Yoshitaka Taguchi, Sadao Shiosaka, Junya Tanaka, Hiroaki Kubota, Yoshitake Terano, Masaya Tohyama, Hiroshi Wada, Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decar☐ylase as a marker Brain Research. ,vol. 295, pp. 13- 25 ,(1984) , 10.1016/0006-8993(84)90811-4
A. N. Nicholson, B. M. Stone, The H1-antagonist mequitazine: Studies on performance and visual function European Journal of Clinical Pharmacology. ,vol. 25, pp. 563- 566 ,(1983) , 10.1007/BF00542129
P. GERVAIS, A. GERVAIS, R. BEULE, W. BIJL, ESSAI COMPARE D'UN NOUVEL ANTIHISTAMINIQUE, LA MEQUITAZINE, ET D'UN PLACEBO Allergy. ,vol. 30, pp. 286- 297 ,(1975) , 10.1111/J.1398-9995.1975.TB00205.X
HEIKKI KARPPANEN, ILARI PAAKKARI, PIRKKO PAAKKARI, RAIMO HUOTARI, ANNA-LIISA ORMA, Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidine Nature. ,vol. 259, pp. 587- 588 ,(1976) , 10.1038/259587A0